Crossmark

Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome

Crossref DOI link: https://doi.org/10.1038/s41591-019-0343-4

Published Online: 2019-02-18

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Beyret, Ergin

Liao, Hsin-Kai

Yamamoto, Mako

Hernandez-Benitez, Reyna

Fu, Yunpeng

Erikson, Galina https://orcid.org/0000-0001-6041-5652
Reddy, Pradeep https://orcid.org/0000-0002-9173-3845
Izpisua Belmonte, Juan Carlos https://orcid.org/0000-0003-0557-8875
License Information

Text and Data Mining valid from 2019-02-18
More Information

Article History

Received: 22 January 2018

Accepted: 21 December 2018

First Online: 18 February 2019

Competing interests

: The authors declare no competing interests.